Korea United obtains process patent for ramipril

Published: 2006-09-28 06:57:00

Updated: 2006-09-28 06:57:00

Korea United Pharms said it acquired a patent for manufacturing process of ramipril, an angiotensin-converting enzyme (ACE) inhibitor, which is unstable in a wide variety of physicochemical conditions.

The invention relates to a formulation and manufacturing process of ramipril in manner such ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK